267 related articles for article (PubMed ID: 34061780)
1. TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies.
Li C; Xia J; Franqui-Machin R; Chen F; He Y; Ashby TC; Teng F; Xu H; Liu D; Gai D; Johnson SK; van Rhee F; Janz S; Shaughnessy JD; Tricot G; Frech I; Zhan F
J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34061780
[TBL] [Abstract][Full Text] [Related]
2. TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myeloma.
Tao Y; Yang G; Yang H; Song D; Hu L; Xie B; Wang H; Gao L; Gao M; Xu H; Xu Z; Wu X; Zhang Y; Zhu W; Zhan F; Shi J
Oncotarget; 2017 Apr; 8(16):26718-26731. PubMed ID: 28157697
[TBL] [Abstract][Full Text] [Related]
3. A Small-Molecule Inhibitor Targeting TRIP13 Suppresses Multiple Myeloma Progression.
Wang Y; Huang J; Li B; Xue H; Tricot G; Hu L; Xu Z; Sun X; Chang S; Gao L; Tao Y; Xu H; Xie Y; Xiao W; Yu D; Kong Y; Chen G; Sun X; Lian F; Zhang N; Wu X; Mao Z; Zhan F; Zhu W; Shi J
Cancer Res; 2020 Feb; 80(3):536-548. PubMed ID: 31732653
[TBL] [Abstract][Full Text] [Related]
4. The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathway.
Wang Y; Dong S; Hu K; Xu L; Feng Q; Li B; Wang G; Chen G; Zhang B; Jia X; Xu Z; Gao X; Zhang H; Xie Y; Lu M; Chang S; Song D; Wu X; Jia Q; Zhu H; Zhou J; Zhu W; Shi J
J Transl Med; 2023 Nov; 21(1):858. PubMed ID: 38012658
[TBL] [Abstract][Full Text] [Related]
5. Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4.
Zhu MX; Wei CY; Zhang PF; Gao DM; Chen J; Zhao Y; Dong SS; Liu BB
J Exp Clin Cancer Res; 2019 Sep; 38(1):409. PubMed ID: 31533816
[TBL] [Abstract][Full Text] [Related]
6. TRIP13 interference inhibits the proliferation and metastasis of thyroid cancer cells through regulating TTC5/p53 pathway and epithelial-mesenchymal transition related genes expression.
Yu L; Xiao Y; Zhou X; Wang J; Chen S; Peng T; Zhu X
Biomed Pharmacother; 2019 Dec; 120():109508. PubMed ID: 31648166
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of thyroid hormone receptor interactor 13 is associated with human hepatocellular carcinoma.
Ju L; Li X; Shao J; Lu R; Wang Y; Bian Z
Oncol Rep; 2018 Dec; 40(6):3794-3802. PubMed ID: 30542731
[TBL] [Abstract][Full Text] [Related]
8. Decreases in different Dnmt3b activities drive distinct development of hematologic malignancies in mice.
Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Haney SL; Opavsky R
J Biol Chem; 2021; 296():100285. PubMed ID: 33450231
[TBL] [Abstract][Full Text] [Related]
9. Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growth.
Hu L; Shen D; Liang D; Shi J; Song C; Jiang K; Menglin Ren ; Du S; Cheng W; Ma J; Li S; Bi X; Barr MP; Fang Z; Xu Q; Li W; Piao H; Meng S
Cancer Lett; 2020 Nov; 493():156-166. PubMed ID: 32860853
[TBL] [Abstract][Full Text] [Related]
10. TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer.
Sheng N; Yan L; Wu K; You W; Gong J; Hu L; Tan G; Chen H; Wang Z
Cell Death Dis; 2018 Mar; 9(3):402. PubMed ID: 29540729
[TBL] [Abstract][Full Text] [Related]
11. Thyroid Receptor-Interacting Protein 13 is Correlated with Progression and Poor Prognosis in Bladder Cancer.
Niu L; Gao Z; Cui Y; Yang X; Li H
Med Sci Monit; 2019 Sep; 25():6660-6668. PubMed ID: 31486418
[TBL] [Abstract][Full Text] [Related]
12. TRIP13 promotes proliferation and invasion of epithelial ovarian cancer cells through Notch signaling pathway.
Zhou XY; Shu XM
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):522-529. PubMed ID: 30720159
[TBL] [Abstract][Full Text] [Related]
13. TRIP 13-dependent pathways promote the development of gastric cancer.
Ni F; Liu X; Xia Y; Zhu H; Li F; Zhang N; Xu H
Funct Integr Genomics; 2023 Jul; 23(3):232. PubMed ID: 37432513
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of TRIP13 drives the tumorigenesis of bladder cancer in association with the EGFR signaling pathway.
Gao Y; Liu S; Guo Q; Zhang S; Zhao Y; Wang H; Li T; Gong Y; Wang Y; Zhang T; Dong Z; Bacich D; Chowdhury WH; Rodriguez R; Wang Z
Int J Biol Sci; 2019; 15(7):1488-1499. PubMed ID: 31337978
[TBL] [Abstract][Full Text] [Related]
15. [Regulation of TRIP13 on Proliferation and Apoptosis of B-Cell Lymphoma Cells and Its Mechanism].
Yan SR; Zhang Q; Liu XC; Yuan JJ; Zhang F; Zhou KS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1485-1492. PubMed ID: 34627428
[TBL] [Abstract][Full Text] [Related]
16. Mad2 Overexpression Uncovers a Critical Role for TRIP13 in Mitotic Exit.
Marks DH; Thomas R; Chin Y; Shah R; Khoo C; Benezra R
Cell Rep; 2017 May; 19(9):1832-1845. PubMed ID: 28564602
[TBL] [Abstract][Full Text] [Related]
17. [Study on the expression of TRIP13 mRNA in chronic lymphocytic leukemia B lymphocyte and the molecular mechanism of TRIP13 mediated JVM-2 cell proliferation and apoptosis].
Zhou KS; Zhang Q; Zhang WT; Liu YY; Wu SS; Zhou J; Wei XD; Song YP
Zhonghua Xue Ye Xue Za Zhi; 2017 Jul; 38(7):618-622. PubMed ID: 28810332
[No Abstract] [Full Text] [Related]
18. Evaluation of the TRIP13 level in breast cancer and insights into potential molecular pathways.
Lan J; Huang J; Tao X; Gao Y; Zhang L; Huang W; Luo J; Liu C; Deng Y; Liu L; Liu X
J Cell Mol Med; 2022 May; 26(9):2673-2685. PubMed ID: 35322916
[TBL] [Abstract][Full Text] [Related]
19. TRIP13 promotes the proliferation and invasion of lung cancer cells via the Wnt signaling pathway and epithelial-mesenchymal transition.
Li ZH; Lei L; Fei LR; Huang WJ; Zheng YW; Yang MQ; Wang Z; Liu CC; Xu HT
J Mol Histol; 2021 Feb; 52(1):11-20. PubMed ID: 33128167
[TBL] [Abstract][Full Text] [Related]
20. Deubiquitination of Chfr, a checkpoint protein, by USP7/HAUSP regulates its stability and activity.
Oh YM; Yoo SJ; Seol JH
Biochem Biophys Res Commun; 2007 Jun; 357(3):615-9. PubMed ID: 17442268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
